Loading the player…
⌘K
Midfielder · St. Louis CITY SC · Compare
vs LASun, Oct 11, 7:00 PM ETMatch page →Xande Silva (Midfielder, St. Louis CITY SC) has 0 goals and 1 assist in 18 MLS appearances in 2025.
Last match
A yes-only price keeps the books' margin, so there is no fair chance to compare his rate with.
Xande Silva's full breakdown holds the game-by-game chart, hit-rate splits and filters, the what-if line and market curve, every book and the line history, closing lines, the projected range, teammates and matchup tools. Checking your player views…
Checking your player views…2024 and 2025
| Date | Opp | Result | Min | G | A | Shots | SOT | Fouls | YC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19 | at DAL | L 0–3 | 29* | 0 | 0 | 0 | 0 | 1 | 0 |
| Jul 5 | at RSL | L 2–3 | 10* | 0 | 0 | 0 | 0 | 0 | 0 |
| Jun 28 | at HOU | L 0–1 | 23* | 0 | 0 | 2 | 0 | 1 | 0 |
| Jun 14 | vs LA | D 3–3 | 1* | 0 | 0 | 0 | 0 | 0 | 0 |
| Jun 8 | at POR | L 1–2 | 2* | 0 | 0 | 2 | 1 | 0 | 0 |
| May 31 | vs SJ | W 2–1 | 49* | 0 | 0 | 2 | 2 | 1 | 1 |
| May 24 | at COL | L 0–1 | 9* | 0 | 0 | 0 | 0 | 0 | 0 |
| May 17 | at MIN | L 0–3 | 19* | 0 | 0 | 0 | 0 | 0 | 0 |
| May 14 | vs SKC | D 2–2 | 31* | 0 | 0 | 1 | 0 | 1 | 0 |
| May 10 | vs SD | L 1–2 | 18* | 0 | 0 | 0 | 0 | 1 | 0 |
Showing 10 of 58 games. The full game log is part of the player's full breakdown (a free account opens 5 players a day; Pro has no limit).
2025
100 = the most per 90 among midfielders; a tie counts half. Rates are goals, assists, shots and shots on target per 90 minutes in league matches. Key passes are not tracked.
13 shots charted in 18 matches · 3 on target · 0 goals
Tap or hover a shot for details.
From box scores (minutes are worked out from the substitutions; * = came off the bench). Prop prices from BetMGM, FanDuel, theScore Bet, DraftKings and Caesars when posted; a yes-only price keeps the books' margin. Hit rates are past matches, not a forecast or a pick. For information only, not betting advice. 21+ only. Gambling problem? Call or text 1-800-GAMBLER.